Levofloxacine Stada

Levofloxacin, the active ingredient in Levofloxacine Stada, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections, including urinary tract, respiratory, and skin infections, in adult patients as determined by a healthcare professional. It is available only by prescription and should be used under medical supervision.

GNH USA supplies Levofloxacine Stada as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across EU and other global markets.

Levofloxacine Stada is a fluoroquinolone antibiotic used to treat bacterial infections in various organ systems. - Urinary tract infection: eradicates susceptible bacteria, relieving symptoms and preventing complications. - Community‑acquired pneumonia: eliminates the causative pathogens, improving respiratory function. - Skin and soft tissue infection: clears infection and promotes wound healing. - Prostatitis: reduces bacterial load in the prostate, alleviating pain and urinary symptoms. - Complicated intra‑abdominal infection: targets mixed aerobic and anaerobic organisms to control infection.

Levofloxacine Stada may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Clostridioides difficile colitis: severe diarrhea with abdominal cramping. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Peripheral neuropathy: tingling or numbness in extremities.

Before prescribing Levofloxacine Stada, clinicians should consider several safety factors. - Renal function: adjust dose in patients with severe impairment. - History of tendon disorders: avoid use in individuals with recent tendon injury. - QT prolongation risk: monitor ECG in patients with cardiac conduction abnormalities. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Drug interactions: review concomitant medications for possible effects. - Store at room temperature: keep in the original container, protect from moisture and light.

Levofloxacine Stada can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce levofloxacin absorption. - Ciprofloxacin or other fluoroquinolones: additive QT‑prolonging effect. - Warfarin: may increase anticoagulant effect and bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened risk of central nervous system stimulation. - Theophylline: levofloxacin can raise serum theophylline levels. - Oral hypoglycemics: possible alteration of blood glucose control.